The Nicaraguan pharmaceutical market will experience strong growth in local currency terms over the next decade owing to the improvement of the country s drug procurement system. In ----, medicine expenditure reached a value of NIO--.-bn (USD---mn), and this is expected to increase to NIO--.-bn (USD---mn) in ----, experiencing a -.- increase in local currency terms and a -.- increase in US dollar terms, owing to continued currency devaluation. ...The Nicaraguan pharmaceutical market will experience strong growth in local currency terms over the next decade owing to the improvement of the country s drug procurement system. In ----, medicine expenditure reached a value of NIO--.-bn (USD---mn), and this is expected to increase to NIO--.-bn (USD---mn) in ----, experiencing a -.- increase in local currency terms and a -.- increase in US dollar terms, owing to continued currency devaluation. From ----, we expect a five-year local currency compound annual growth rate (CAGR) of -.- (-.- in US dollars), to a ---- value of NIO--.-bn (USD---mn). ...Indeed, many patients either end up purchasing only part of what they are prescribed or nothing at all. In an effort to remedy this, the local government has taken steps to include traditional medicines in the country s national healthcare service as a way to offer more affordable medicines to the population.
...BMI View: The combination of economic difficulties, low per capita healthcare expenditure and an unfriendly business environment will continue to make it difficult for Nicaragua to attract foreign investment in the healthcare sector. The public healthcare system will continue to struggle to provide basic healthcare coverage and consistent access to essential medicines in the foreseeable future. ...BMI View: The combination of economic difficulties, low per capita healthcare expenditure and an unfriendly business environment will continue to make it difficult for Nicaragua to attract foreign investment in the healthcare sector. The public healthcare system will continue to struggle to provide basic healthcare coverage and consistent access to essential medicines in the foreseeable future. Much more progress will be needed before it can offer a competitive investment setting compared with its regional peers with much larger healthcare markets. ...The public healthcare system will continue to struggle to provide basic healthcare coverage and consistent access to essential medicines in the foreseeable future. Much more progress will be needed before it can offer a competitive investment setting compared with its regional peers with much larger healthcare markets.
...All information contained in this publication is copyrighted in the name of Business Monitor International Ltd, and as such no part of this publication may be reproduced, repackaged, redistributed, resold in whole or in any part, or used in any form or by any means graphic, electronic or mechanical, including photocopying, recording, taping, or by information storage or retrieval, or by any other means, without the express written consent of the publisher. ...
...